相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA
Frits A. Wijburg et al.
MOLECULAR GENETICS AND METABOLISM (2022)
Fluoxetine ameliorates mucopolysaccharidosis type IIIA
Antonella Capuozzo et al.
MOLECULAR THERAPY (2022)
Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease
Jennifer T. Saville et al.
HUMAN GENE THERAPY (2021)
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders
Maria De Risi et al.
NATURE COMMUNICATIONS (2021)
Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment
Katherine Ackerman Porter et al.
NEUROLOGY AND THERAPY (2021)
Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA
Jennifer T. Saville et al.
MOLECULAR GENETICS AND METABOLISM (2020)
The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease
Antonio Monaco et al.
MOLECULAR THERAPY (2020)
Retinal Degeneration in MPS-IIIA Mouse Model
Daniela Intartaglia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Therapy development for the mucopolysaccharidoses: Updated consensus recommendations for neuropsychological endpoints
Johanna H. van der Lee et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Rigor and reproducibility in rodent behavioral research
Maria Gulinello et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2019)
Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α-synuclein
K. Soe et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
Nicolina Cristina Sorrentino et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice
Susanne Gustavsson et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2019)
MPS-IIIA mice acquire autistic behaviours with age
Adeline A. Lau et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Practical management of behavioral problems in mucopolysaccharidoses disorders
Maria L. Escolar et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Selective normalisation of regional brain bis(monoacylglycero)phosphate in the mucopolysaccharidosis 1 (Hurler) mouse
Jennifer T. Saville et al.
EXPERIMENTAL NEUROLOGY (2016)
N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice
Xenia Kaidonis et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery
Haiyan Fu et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Burrowing and nest building behavior as indicators of well-being in mice
Paulin Jirkof
JOURNAL OF NEUROSCIENCE METHODS (2014)
Acquired Autistic Behaviors in Children with Mucopolysaccharidosis Type IIIA
Robin K. Rumsey et al.
JOURNAL OF PEDIATRICS (2014)
Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism
Ahmed El-Kordi et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
The Mysterious Motivational Functions of Mesolimbic Dopamine
John D. Salamone et al.
NEURON (2012)
Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
Alex Langford-Smith et al.
PLOS ONE (2011)
Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C)
J. J. P. VAN DE Kamp et al.
CLINICAL GENETICS (2010)
Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease
Colm Cunningham et al.
BIOLOGICAL PSYCHIATRY (2009)
Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes
Alessandro Fraldi et al.
HUMAN MOLECULAR GENETICS (2007)
Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of NIPSIIIA
Ainslie L. K. Roberts et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Targeting cellular prion protein reverses early coanitive deficits and neurophysiological dysfunction in prion-infected mice
Giovanna R. Mallucci et al.
NEURON (2007)
The cerebellum and motor dysfunction in neuropsychiatric disorders
E. Gowen et al.
CEREBELLUM (2007)
Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA
Allison C. Crawley et al.
BRAIN RESEARCH (2006)
Assessing nest building in mice
Robert M. J. Deacon
NATURE PROTOCOLS (2006)
A review of measures of quality of life for children with chronic illness
C Eiser et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
分享论文
